TITLE

Dried Blood Spots Perform Well in Viral Load Monitoring of Patients Who Receive Antiretroviral Treatment in Rural Tanzania

AUTHOR(S)
Johannessen, Asgeir; Garrido, Carolina; Zahonero, Natalia; Sandvik, Leiv; Naman, Ezra; Kivuyo, Sokoine L.; Kasubi, Mabula J.; Gundersen, Svein G.; Bruun, Johan N.; de Mendoza, Carmen
PUB. DATE
September 2009
SOURCE
Clinical Infectious Diseases;9/15/2009, Vol. 49 Issue 6, p976
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Monitoring of antiretroviral treatment (ART) with human immunodeficiency virus (HIV) viral loads, as recommended in industrialized countries, is rarely available in resource-limited settings because of the high costs and stringent requirements for storage and transport of plasma. Dried blood spots (DBS) can be an alternative to plasma, but the use of DBS has not been assessed under field conditions in rural Africa. The present study investigates the performance of DBS in HIV viral load monitoring of patients who received ART in rural Tanzania. Patients and Methods. From November 2007 through June 2008, parallel plasma and DBS specimens were obtained from patients who received ART at Haydom Lutheran Hospital in rural Tanzania. DBS specimens were stored at tropical room temperature for 3 weeks before testing with the NucliSENS EasyQ HIV-1 v1.2 assay. Results obtained with DBS were compared with results obtained with use of a gold-standard plasma assay. Results. Ninety-eight plasma-DBS pairs were compared, and plasma viral loads ranged from <40 to >1,000,000 copies/mL. The correlation between plasma and DBS viral load was strong (R² = 0.75). The mean difference (± standard deviation) was 0.04 ± 0.57 log10 copies/mL, and only 8 samples showed >1 log10 copies/mL difference. HIV type 1 RNA was detected in 7%, 60%, and 100% of DBS specimens with corresponding plasma viral loads of 40-999, 1000-2999, and ⩾3000 copies/mL, respectively. Conclusions. DBS, in combination with the NucliSENS EasyQ HIV-1 v1.2 asay, performed well in monitoring HIV viral loads in patients who received ART in rural Tanzania, although the sensitivity was reduced when viral burden was low. The use of DBS can simplify virological monitoring in resource-limited settings.
ACCESSION #
43982078

 

Related Articles

  • HIV-1 RNA May Decline More Slowly in Semen than in Blood following Initiation of Efavirenz-Based Antiretroviral Therapy. Graham, Susan M.; Holte, Sarah E.; Dragavon, Joan A.; Ramko, Kelly M.; Mandaliya, Kishor N.; McClelland, R. Scott; Peshu, Norbert M.; Sanders, Eduard J.; Krieger, John N.; Coombs, Robert W.; Lama, Javier R. // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Objectives: Antiretroviral therapy (ART) decreases HIV-1 RNA levels in semen and reduces sexual transmission from HIV-1- infected men. Our objective was to study the time course and magnitude of seminal HIV-1 RNA decay after initiation of efavirenz-based ART among 13 antiretroviral-naïve...

  • Association of visceral adiposity with increased intrarenal artery resistive index in HIV-1-infected patients receiving highly active antiretroviral therapy. Grima, Pierfrancesco; Zizza, Antonella; Guido, Marcello; Tundo, Paolo; Chiavaroli, Roberto // Indian Journal of Sexually Transmitted Diseases;2010, Vol. 31 Issue 1, p16 

    Purpose: The aim of our study was to evaluate whether perirenal fat thickness (PRFT), a parameter of central obesity, is related to kidney function and intrarenal artery resistive index (IARI) in human immunodeficiency virus (HIV)-1-infected patients. Materials and Methods: We enrolled 102...

  • Experiences and Perceptions of Patients with 100% Adherence to Highly Active Antiretroviral Therapy: A Qualitative Study. Sidat, Mohsin; Fairley, Christopher; Grierson, Jeffrey // AIDS Patient Care & STDs;Jul2007, Vol. 21 Issue 7, p509 

    A decade has passed since the introduction of highly active antiretroviral therapy (HAART) as standard of care for HIV/AIDS patients. The success of HAART is largely dependent on almost 100% adherence to it. In this study our primary aim was to understand from patients' own perspectives and...

  • Factors Associated With Virological Failure in HIV-1-Infected Patients Receiving Darunavir/ Ritonavir Monotherapy. Lambert-Niclot, Sidonie; Flandre, Philippe; Valantin, Marc-Antoine; Peytavin, Gilles; Duvivier, Claudine; Haim-Boukobza, Stephanie; Algarte-Genin, Michele; Yazdanpanah, Yazdan; Girard, Pierre-Marie; Katlama, Christine; Calvez, Vincent; Marcelin, Anne-Genevieve // Journal of Infectious Diseases;10/15/2011, Vol. 204 Issue 8, p1211 

    Background. Our objective was to determine virological and clinical characteristics associated with virological failure in human immunodeficiency virus (HIV)-infected patients switching to darunavir/ritonavir (DRV/r) monotherapy. Methods. The main outcome was virologic rebound, defined as 2...

  • Early Viral Suppression Predicting Long-term Treatment Success Among HIV Patients Commencing NNRTI-based Antiretroviral Therapy. Soe, Aung Naing; Tansuphasawadikul, Somsit; Phonrat, Benjaluck; Boonpok, Lamom; Tepsupa, Sirima; Japrasert, Chayaporn; Maek-a-nantawat, Wirach // Journal of Antivirals & Antiretrovirals;2010, Vol. 2 Issue 2, p33 

    Non-nucleoside reverse transcriptase inhibitor (NNRTI) -based antiretroviral therapy (ART) regimens have been recommended and widely used in resource-limited settings because of their reliable effi cacy, low pill burden, and low cost. This study sought to determine outcomes and toxicities of...

  • Are All Subtypes Created Equal? The Effectiveness of Antiretroviral Therapy against Non-Subtype B HIV-1. Pond, Sergei L. Kosakovsky; Smith, Davey M. // Clinical Infectious Diseases;5/1/2009, Vol. 48 Issue 9, p1306 

    The article reports on the study regarding the effectiveness of modern combination of antiretroviral therapy against non-subtype B HIV-1 in the U.S. It states that the study examined the rates of viral suppression with antiretroviral therapy during infection with subtypes A, C, and D and with...

  • Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. Kitahata, Mari M.; Reed, Shelby D; Dillingham, Peter W.; Van Rompaey, Stephen E.; Young, Alicia A.; Harrington, Robert D.; Holmes, King K. // International Journal of STD & AIDS;Dec2004, Vol. 15 Issue 12, p803 

    Although adherence to HAART at a level above 95% has been associated with optimal viral suppression, the impact of different levels of adherence on long-term clinical outcomes has not been determined. We used an objective pharmacy-based measure to examine the association between three levels of...

  • Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. Kitahata, Mari M.; Reed, Shelby D; Dillingham, Peter W.; Van Rompaey, Stephen E.; Young, Alicia A.; Harrington, Robert D.; Holmes, King K. // International Journal of STD & AIDS;Dec2004, Vol. 15 Issue 12, p803 

    Although adherence to HAART at a level above 95% has been associated with optimal viral suppression, the impact of different levels of adherence on long-term clinical outcomes has not been determined. We used an objective pharmacy-based measure to examine the association between three levels of...

  • Virologic failure in an HIV-infected woman given desogestrel for excessive menstrual bleeding. Cattaneo, Dario; Meraviglia, Paola; Beretta, Rosangela; Baldelli, Sara; Cozzi, Valeria; Milani, Greta; Clementi, Emilio // European Journal of Clinical Pharmacology;Apr2011, Vol. 67 Issue 4, p429 

    The article presents a case study of a 38-year-old, HIV-positive woman from Ivory Coast who experienced excessive menstrual bleeding with methrorragia and low blood hemoglobin concentrations during a routine outpatient visit for which her doctor prescribed the hormone desogestrel. Topics include...

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics